ARCHIVES

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

Kulig Will Oversee Outcomes Research at NCCN

September 30, 2011

Intramural AIDS Vaccine Research Center In Development By NCI, NIAID Scientists

June 13, 1997

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

House Approves $619M Increase For NIH.

February 2, 2007

In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse

June 6, 1997

Interferon Results Cool Expectations, But Other Reports At ASCO/AACR Demonstrate Solid Progress

June 6, 1980